Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 1
1999 2
2000 2
2001 4
2002 2
2003 2
2004 2
2005 4
2006 2
2007 1
2008 3
2009 2
2010 2
2011 3
2012 1
2013 2
2014 2
2015 5
2016 10
2017 5
2018 3
2019 4
2020 8
2021 2
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, Gianferante M, Spector LG, Morton LM, Karyadi D, Robison LL, Armstrong GT, Bhatia S, Song L, Pankratz N, Pinheiro M, Gastier-Foster JM, Gorlick R, de Toledo SRC, Petrilli AS, Patino-Garcia A, Lecanda F, Gutierrez-Jimeno M, Serra M, Hattinger C, Picci P, Scotlandi K, Flanagan AM, Tirabosco R, Amary MF, Kurucu N, Ilhan IE, Ballinger ML, Thomas DM, Barkauskas DA, Mejia-Baltodano G, Valverde P, Hicks BD, Zhu B, Wang M, Hutchinson AA, Tucker M, Sampson J, Landi MT, Freedman ND, Gapstur S, Carter B, Hoover RN, Chanock SJ, Savage SA. Mirabello L, et al. Among authors: hattinger c. JAMA Oncol. 2020 May 1;6(5):724-734. doi: 10.1001/jamaoncol.2020.0197. JAMA Oncol. 2020. PMID: 32191290 Free PMC article.
The pharmacogenomics of osteosarcoma.
Serra M, Hattinger CM. Serra M, et al. Among authors: hattinger cm. Pharmacogenomics J. 2017 Jan;17(1):11-20. doi: 10.1038/tpj.2016.45. Epub 2016 May 31. Pharmacogenomics J. 2017. PMID: 27241064 Review.
Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors.
Scotlandi K, Hattinger CM, Pellegrini E, Gambarotti M, Serra M. Scotlandi K, et al. Among authors: hattinger cm. Cells. 2020 Apr 14;9(4):968. doi: 10.3390/cells9040968. Cells. 2020. PMID: 32295254 Free PMC article. Review.
Advances in emerging drugs for osteosarcoma.
Hattinger CM, Fanelli M, Tavanti E, Vella S, Ferrari S, Picci P, Serra M. Hattinger CM, et al. Expert Opin Emerg Drugs. 2015 Sep;20(3):495-514. doi: 10.1517/14728214.2015.1051965. Epub 2015 Jun 1. Expert Opin Emerg Drugs. 2015. PMID: 26021401 Review.
Emerging drugs for high-grade osteosarcoma.
Hattinger CM, Pasello M, Ferrari S, Picci P, Serra M. Hattinger CM, et al. Expert Opin Emerg Drugs. 2010 Dec;15(4):615-34. doi: 10.1517/14728214.2010.505603. Epub 2010 Aug 9. Expert Opin Emerg Drugs. 2010. PMID: 20690888 Review.
Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.
Gianferante DM, Moore A, Spector LG, Wheeler W, Yang T, Hubbard A, Gorlick R, Patiño-Garcia A, Lecanda F, Flanagan AM, Amary F, Andrulis IL, Wunder JS, Thomas DM, Ballinger ML, Serra M, Hattinger C, Demerath E, Johnson W, Birmann BM, De Vivo I, Giles G, Teras LR, Arslan A, Vermeulen R, Sample J, Freedman ND, Huang WY, Chanock SJ, Savage SA, Berndt SI, Mirabello L. Gianferante DM, et al. Among authors: hattinger c. Cancer Epidemiol. 2023 Aug 16:102432. doi: 10.1016/j.canep.2023.102432. Online ahead of print. Cancer Epidemiol. 2023. PMID: 37596165 Free article.
75 results